Cargando…

Identification of Host Cellular Protein Substrates of SARS-COV-2 Main Protease

The novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of coronavirus disease-19 (COVID-19) being associated with severe pneumonia. Like with other viruses, the interaction of SARS-CoV-2 with host cell proteins is necessary for successful replication, and cleav...

Descripción completa

Detalles Bibliográficos
Autores principales:	Miczi, Márió, Golda, Mária, Kunkli, Balázs, Nagy, Tibor, Tőzsér, József, Mótyán, János András
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7765187/ https://www.ncbi.nlm.nih.gov/pubmed/33333742 http://dx.doi.org/10.3390/ijms21249523

Ejemplares similares

Analysis of the efficacy of HIV protease inhibitors against SARS-CoV-2′s main protease
por: Mahdi, Mohamed, et al.
Publicado: (2020)

Dimer Interface Organization is a Main Determinant of Intermonomeric Interactions and Correlates with Evolutionary Relationships of Retroviral and Retroviral-Like Ddi1 and Ddi2 Proteases
por: Mótyán, János András, et al.
Publicado: (2020)

Identification of SARS-CoV-2 Main Protease (Mpro) Cleavage Sites Using Two-Dimensional Electrophoresis and In Silico Cleavage Site Prediction
por: Miltner, Noémi, et al.
Publicado: (2023)

Data supporting Ni-NTA magnetic bead-based fluorescent protease assay using recombinant fusion protein substrates
por: Mótyán, János András, et al.
Publicado: (2018)

Specificity of the HIV-1 Protease on Substrates Representing the Cleavage Site in the Proximal Zinc-Finger of HIV-1 Nucleocapsid Protein
por: Mótyán, János András, et al.
Publicado: (2021)

Development of a Bio-Layer Interferometry-Based Protease Assay Using HIV-1 Protease as a Model
por: Miczi, Márió, et al.
Publicado: (2021)

Biochemical Characterization of Human Retroviral-Like Aspartic Protease 1 (ASPRV1)
por: Golda, Mária, et al.
Publicado: (2020)

Potential Resistance of SARS-CoV-2 Main Protease (Mpro) against Protease Inhibitors: Lessons Learned from HIV-1 Protease
por: Mótyán, János András, et al.
Publicado: (2022)

Functional Study of the Retrotransposon-Derived Human PEG10 Protease
por: Golda, Mária, et al.
Publicado: (2020)

Biochemical Characterization, Specificity and Inhibition Studies of HTLV-1, HTLV-2, and HTLV-3 Proteases
por: Kassay, Norbert, et al.
Publicado: (2021)

Y44A Mutation in the Acidic Domain of HIV-2 Tat Impairs Viral Reverse Transcription and LTR-Transactivation
por: Szojka, Zsófia, et al.
Publicado: (2020)

Biochemical characterization of Ty1 retrotransposon protease
por: Gazda, Lívia Diána, et al.
Publicado: (2020)

Specificity Studies of the Venezuelan Equine Encephalitis Virus Non-Structural Protein 2 Protease Using Recombinant Fluorescent Substrates
por: Bozóki, Beáta, et al.
Publicado: (2020)

Inhibition Profiling of Retroviral Protease Inhibitors Using an HIV-2 Modular System
por: Mahdi, Mohamed, et al.
Publicado: (2015)

Different Mutation Tolerance of Lentiviral (HIV-1) and Deltaretroviral (BLV and HTLV) Protease Precursors
por: Mótyán, János András, et al.
Publicado: (2022)

Research Applications of Proteolytic Enzymes in Molecular Biology
por: Mótyán, János András, et al.
Publicado: (2013)

Effect of internal cleavage site mutations in human immunodeficiency virus type 1 capsid protein on its structure and function
por: Tóth, Ferenc, et al.
Publicado: (2016)

A molecular model of the full-length human NOD-like receptor family CARD domain containing 5 (NLRC5) protein
por: Mótyán, János András, et al.
Publicado: (2013)

Comparative Studies on Retroviral Proteases: Substrate Specificity
por: Tözsér, József
Publicado: (2010)

Early suppression of antiviral host response and protocadherins by SARS-CoV-2 Spike protein in THP-1-derived macrophage-like cells
por: Miltner, Noémi, et al.
Publicado: (2022)

Characterization of host substrates of SARS-CoV-2 main protease
por: Melano, Ivonne, et al.
Publicado: (2023)

Compounds with Antiviral, Anti-Inflammatory and Anticancer Activity Identified in Wine from Hungary’s Tokaj Region via High Resolution Mass Spectrometry and Bioinformatics Analyses
por: Kalló, Gergő, et al.
Publicado: (2020)

Cellular Proteo-Transcriptomic Changes in the Immediate Early-Phase of Lentiviral Transduction
por: Linkner, Tamás Richárd, et al.
Publicado: (2021)

Challenges of short substrate analogues as SARS-CoV-2 main protease inhibitors
por: Ullrich, Sven, et al.
Publicado: (2021)

In Silico Substrate-Binding Profiling for SARS-CoV-2 Main Protease (M(pro)) Using Hexapeptide Substrates
por: Zabo, Sophakama, et al.
Publicado: (2023)

Defining the substrate envelope of SARS-CoV-2 main protease to predict and avoid drug resistance
por: Shaqra, Ala M., et al.
Publicado: (2022)

N‐Terminomics for the Identification of In Vitro Substrates and Cleavage Site Specificity of the SARS‐CoV‐2 Main Protease
por: Koudelka, Tomas, et al.
Publicado: (2020)

Efficiency Improvements and Discovery of New Substrates for a SARS-CoV-2 Main Protease FRET Assay
por: Dražić, Tonko, et al.
Publicado: (2021)

Structural basis for replicase polyprotein cleavage and substrate specificity of main protease from SARS-CoV-2
por: Zhao, Yao, et al.
Publicado: (2022)

Peptide aldehyde inhibitors challenge the substrate specificity of the SARS-coronavirus main protease
por: Zhu, Lili, et al.
Publicado: (2011)

Characterization of SARS main protease and inhibitor assay using a fluorogenic substrate()
por: Kuo, Chih-Jung, et al.
Publicado: (2004)

Activation and maturation of SARS-CoV main protease
por: Xia, Bin, et al.
Publicado: (2011)

SARS-CoV-2 main protease cleaves MAGED2 to antagonize host antiviral defense
por: Ju, Xiaohui, et al.
Publicado: (2023)

SARS-CoV-2 host tropism: An in silico analysis of the main cellular factors
por: Rangel, H.R., et al.
Publicado: (2020)

Mutation of Glu-166 Blocks the Substrate-Induced Dimerization of SARS Coronavirus Main Protease
por: Cheng, Shu-Chun, et al.
Publicado: (2010)

The SARS-CoV-2 main protease as drug target
por: Ullrich, Sven, et al.
Publicado: (2020)

Topological analysis of SARS CoV-2 main protease
por: Estrada, Ernesto
Publicado: (2020)

Potential SARS-CoV-2 main protease inhibitors
por: Banerjee, Riddhidev, et al.
Publicado: (2021)

Developing inhibitors of the SARS-CoV-2 main protease
por: Seitz, Christian, et al.
Publicado: (2022)

Allosteric Hotspots in the Main Protease of SARS-CoV-2
por: Strömich, Léonie, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_spfl3oetocoet31oq85rjdon07